Paper39755677
Preclinical and clinical study on type 3 metabotropic glutamate receptors in Parkinson's disease.
Di Menna L and 31 others. NPJ Parkinsons Dis, 2025. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Preclinical and clinical study on type 3 metabotropic glutamate receptors in Parkinson's disease. Papers, record 39755677. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39755677
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Preclinical and clinical study on type 3 metabotropic glutamate receptors in Parkinson's disease.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants19
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| RF-2018-123-68289 | Ministero della Salute (Ministry of Health, Italy) | PubMed | ||
| RF-2018-123-68289 | Ministero della Salute (Ministry of Health, Italy) | PubMed | ||
| RF-2018-123-68289 | Ministero della Salute (Ministry of Health, Italy) | PubMed | ||
| RF-2018-123-68289 | Ministero della Salute (Ministry of Health, Italy) | PubMed | ||
| RF-2018-123-68289 | Ministero della Salute (Ministry of Health, Italy) | PubMed | ||
| RF-2018-123-68289 | Ministero della Salute (Ministry of Health, Italy) | PubMed | ||
| RF-2018-123-68289 | Ministero della Salute (Ministry of Health, Italy) | PubMed | ||
| RF-2018-123-68289 | Ministero della Salute (Ministry of Health, Italy) | PubMed | ||
| RF-2018-123-68289 | Ministero della Salute (Ministry of Health, Italy) | PubMed | ||
| RF-2018-123-68289 | Ministero della Salute (Ministry of Health, Italy) | PubMed | ||
| RF-2018-123-68289 | Ministero della Salute (Ministry of Health, Italy) | PubMed | ||
| RF-2018-123-68289 | Ministero della Salute (Ministry of Health, Italy) | PubMed | ||
| RF-2018-123-68289 | Ministero della Salute (Ministry of Health, Italy) | PubMed | ||
| RF-2018-123-68289 | Ministero della Salute (Ministry of Health, Italy) | PubMed | ||
| E64117000190001 | Ministero dell'Istruzione, dell'Università e della Ricerca (Ministry of Education, University and Research) | PubMed | ||
| E64117000190001 | Ministero dell'Istruzione, dell'Università e della Ricerca (Ministry of Education, University and Research) | PubMed | ||
| E64117000190001 | Ministero dell'Istruzione, dell'Università e della Ricerca (Ministry of Education, University and Research) | PubMed | ||
| E64117000190001 | Ministero dell'Istruzione, dell'Università e della Ricerca (Ministry of Education, University and Research) | PubMed | ||
| E64117000190001 | Ministero dell'Istruzione, dell'Università e della Ricerca (Ministry of Education, University and Research) | PubMed |
Source PubMed
References64
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21705423 | Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys. | Brain | 2011 | https://conductscience.org/library/papers/21705423 | PubMed |
| 2 | 18361474 | The evolution of disability in Parkinson disease. | Mov Disord | 2008 | https://conductscience.org/library/papers/18361474 | PubMed |
| 3 | 19410592 | Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease. | Physiol Behav | 2009 | https://conductscience.org/library/papers/19410592 | PubMed |
| 4 | 30687016 | Idebenone Alleviates Neuroinflammation and Modulates Microglial Polarization in LPS-Stimulated BV2 Cells and MPTP-Induced Parkinson's Disease Mice. | Front Cell Neurosci | 2018 | https://conductscience.org/library/papers/30687016 | PubMed |
| 5 | 35218231 | A Randomized, Double-Blind, Controlled Phase II Study of Foliglurax in Parkinson's Disease. | Mov Disord | 2022 | https://conductscience.org/library/papers/35218231 | PubMed |
| 6 | 16720584 | SNPStats: a web tool for the analysis of association studies. | Bioinformatics | 2006 | https://conductscience.org/library/papers/16720584 | PubMed |
| 7 | 6607092 | Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey. | Brain Res | 1984 | https://conductscience.org/library/papers/6607092 | PubMed |
| 8 | 3430576 | The efficiency of systematic sampling in stereology and its prediction. | J Microsc | 1987 | https://conductscience.org/library/papers/3430576 | PubMed |
| 9 | 25792075 | Are studies of motor cortex plasticity relevant in human patients with Parkinson's disease? | Clin Neurophysiol | 2016 | https://conductscience.org/library/papers/25792075 | PubMed |
| 10 | 26237365 | Dynamic rewiring of neural circuits in the motor cortex in mouse models of Parkinson's disease. | Nat Neurosci | 2015 | https://conductscience.org/library/papers/26237365 | PubMed |
| 11 | 21159998 | Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective. | Mol Pharmacol | 2011 | https://conductscience.org/library/papers/21159998 | PubMed |
| 12 | 14749427 | Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. | J Neurosci | 2004 | https://conductscience.org/library/papers/14749427 | PubMed |
| 13 | 10066254 | Glial cell line-derived neurotrophic factor rescues target-deprived sympathetic spinal cord neurons but requires transforming growth factor-beta as cofactor in vivo. | J Neurosci | 1999 | https://conductscience.org/library/papers/10066254 | PubMed |
| 14 | 26500044 | Chronic and progressive Parkinson's disease MPTP model in adult and aged mice. | J Neurochem | 2016 | https://conductscience.org/library/papers/26500044 | PubMed |
| 15 | 21036182 | Metabotropic glutamate receptors: from the workbench to the bedside. | Neuropharmacology | 2011 | https://conductscience.org/library/papers/21036182 | PubMed |
| 16 | 18256595 | Expression of a GRM3 splice variant is increased in the dorsolateral prefrontal cortex of individuals carrying a schizophrenia risk SNP. | Neuropsychopharmacology | 2008 | https://conductscience.org/library/papers/18256595 | PubMed |
| 17 | 27296644 | The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia. | Curr Neuropharmacol | 2016 | https://conductscience.org/library/papers/27296644 | PubMed |
| 18 | 19672295 | Activation of mGlu3 receptors stimulates the production of GDNF in striatal neurons. | PLoS One | 2009 | https://conductscience.org/library/papers/19672295 | PubMed |
| 19 | 29901693 | Neurophysiological correlates of bradykinesia in Parkinson's disease. | Brain | 2018 | https://conductscience.org/library/papers/29901693 | PubMed |
| 20 | 33037859 | The Pathophysiological Correlates of Parkinson's Disease Clinical Subtypes. | Mov Disord | 2021 | https://conductscience.org/library/papers/33037859 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42350763 | Targeting GPCR Signaling in Parkinson's Disease: From Molecular Pathology to Exercise-Based Therapeutics. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42350763 | PubMed |
| 42305118 | Decoding GPCR signaling in living cells to advance early therapeutic discovery for neurological disorders. | Front Mol Neurosci | 2026 | https://conductscience.org/library/papers/42305118 | PubMed |
| 41904982 | Neurotransmitter Dysregulation in Parkinson's Disease: Pathophysiological Insights and Therapeutic Perspectives. | ACS Chem Neurosci | 2026 | https://conductscience.org/library/papers/41904982 | PubMed |
| 41073451 | Targeting metabotropic glutamate receptors for symptomatic and disease-modifying treatment in Parkinson's disease. | NPJ Parkinsons Dis | 2025 | https://conductscience.org/library/papers/41073451 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GRM3 | 2913 | PubTator's text mining | https://conductscience.org/library/genes/2913 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39755677
GET https://conductscience.org/api/papers/v1/39755677/authors?page=2